1·The insulin-sensitising drug rosiglitazone enhanced protection afforded by low levels of insulin, the study showed.
研究显示，提高胰岛素敏感性的药物罗格列酮增强了低水平胰岛素下蛋白质的耐受性。
2·But they say that despite these limitations, patients and providers should consider the potential for serious adverse cardiac effects of treatment with rosiglitazone.
但他们说，尽管有这些限制，病人和供者应考虑到用罗格列酮治疗中潜在的严重不良的心脏治疗。
3·They and their patients have been very worried about the cardiovascular safety of rosiglitazone due to the meta analysis paper from New England Journal of Medicine.
因为最近在《新英格兰医学杂志》上发表的那篇荟萃分析，他们和他们的患者现在很担心罗格列酮的心血管安全性问题。
4·The only other drug in this class is Avandia (rosiglitazone). The FDA has no clinical information associating Avandia with bladder cancer in patients receiving that drug.
该类中唯一的另一种药是文迪雅（罗格列酮）。FDA没有临床资料将文迪雅与接受该药患者的膀胱癌联系联系起来。
5·Objective To investigate the effects of rosiglitazone on endothelium-dependent vasodilation in patients with Type 2 diabetes.
目的：观察罗格列酮对2型糖尿病患者内皮依赖性血管舒张功能的影响。